← Back to headlines
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.
17 Mar, 18:28 — 17 Mar, 18:28
Related Stories
Lionel Richie Hospitalized in ICU After Collapsing During St. Louis Concert
38m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
1h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
4h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
12h ago